Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.
Blood
; 2024 Aug 12.
Article
in En
| MEDLINE
| ID: mdl-39133932
ABSTRACT
The European LeukemiaNet (ELN) genetic risk classifications were developed based on data from younger adults receiving intensive chemotherapy. Emerging analyses from patients receiving less-intensive therapies prompted a proposal for an ELN genetic risk classification specifically for this patient population.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Blood
Year:
2024
Document type:
Article
Affiliation country:
Germany
Country of publication:
United States